These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24013203)

  • 1. A new self-controlled case series method for analyzing spontaneous reports of adverse events after vaccination.
    Escolano S; Hill C; Tubert-Bitter P
    Am J Epidemiol; 2013 Nov; 178(9):1496-504. PubMed ID: 24013203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intussusception risk after RotaTeq vaccination: evaluation from worldwide spontaneous reporting data using a self-controlled case series approach.
    Escolano S; Hill C; Tubert-Bitter P
    Vaccine; 2015 Feb; 33(8):1017-20. PubMed ID: 25596460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmarketing monitoring of intussusception after RotaTeq vaccination--United States, February 1, 2006-February 15, 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(10):218-22. PubMed ID: 17363890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Post-licensure passive safety surveillance of rotavirus vaccines: reporting sensitivity for intussusception].
    Pérez-Vilar S; Díez-Domingo J; Gomar-Fayos J; Pastor-Villalba E; Sastre-Cantón M; Puig-Barberà J
    An Pediatr (Barc); 2014 Aug; 81(2):77-85. PubMed ID: 24252603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus vaccination and intussusception: can we decrease temporally associated background cases of intussusception by restricting the vaccination schedule?
    Tai JH; Curns AT; Parashar UD; Bresee JS; Glass RI
    Pediatrics; 2006 Aug; 118(2):e258-64. PubMed ID: 16882770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More on RotaShield and intussusception: the role of age at the time of vaccination.
    Simonsen L; Viboud C; Elixhauser A; Taylor RJ; Kapikian AZ
    J Infect Dis; 2005 Sep; 192 Suppl 1():S36-43. PubMed ID: 16088803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of postlicensure safety of rotavirus vaccines, with emphasis on intussusception.
    Bines JE; Patel M; Parashar U
    J Infect Dis; 2009 Nov; 200 Suppl 1():S282-90. PubMed ID: 19817611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007.
    Haber P; Patel M; Izurieta HS; Baggs J; Gargiullo P; Weintraub E; Cortese M; Braun MM; Belongia EA; Miller E; Ball R; Iskander J; Parashar UD
    Pediatrics; 2008 Jun; 121(6):1206-12. PubMed ID: 18519491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intussusception and rotavirus vaccination: a review of the available evidence.
    Patel MM; Haber P; Baggs J; Zuber P; Bines JE; Parashar UD
    Expert Rev Vaccines; 2009 Nov; 8(11):1555-64. PubMed ID: 19863248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intussusception following rotavirus vaccination in the Valencia Region, Spain.
    Pérez-Vilar S; Díez-Domingo J; Puig-Barberà J; Gil-Prieto R; Romio S
    Hum Vaccin Immunother; 2015; 11(7):1848-52. PubMed ID: 26083707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Intussusception with Rotavirus Vaccine.
    Kalaiselvan V; Thota P; Kumar V; Rathore MS; Thota A; Singh GN
    Indian J Pediatr; 2017 Feb; 84(2):97-100. PubMed ID: 27641974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotavirus live, oral, pentavalent vaccine.
    Tom-Revzon C
    Clin Ther; 2007 Dec; 29(12):2724-37. PubMed ID: 18201590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suspension of rotavirus vaccine after reports of intussusception--United States, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Sep; 53(34):786-9. PubMed ID: 15343145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotavirus vaccines and intussusception risk.
    Bines JE
    Curr Opin Gastroenterol; 2005 Jan; 21(1):20-5. PubMed ID: 15687880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants.
    Laserson KF; Nyakundi D; Feikin DR; Nyambane G; Cook E; Oyieko J; Ojwando J; Rivers SB; Ciarlet M; Neuzil KM; Breiman RF
    Vaccine; 2012 Apr; 30 Suppl 1():A61-70. PubMed ID: 22520138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intussusception and rotavirus vaccines.
    Bines J
    Vaccine; 2006 May; 24(18):3772-6. PubMed ID: 16099078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-marketing monitoring of intussusception after rotavirus vaccination in Japan.
    Bauchau V; Van Holle L; Mahaux O; Holl K; Sugiyama K; Buyse H
    Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):765-70. PubMed ID: 26013569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intussusception among recipients of rotavirus vaccine--United States, 1998-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jul; 48(27):577-81. PubMed ID: 10428095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotavirus vaccines: targeting the developing world.
    Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
    J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.